These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 24919159

  • 1. Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.
    Anantasit N, Boyd JH, Walley KR, Russell JA.
    Crit Care Med; 2014 Aug; 42(8):1812-20. PubMed ID: 24919159
    [Abstract] [Full Text] [Related]

  • 2. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock.
    Nakada TA, Russell JA, Boyd JH, Aguirre-Hernandez R, Thain KR, Thair SA, Nakada E, McConechy M, Walley KR.
    Am J Respir Crit Care Med; 2010 Jan 15; 181(2):143-9. PubMed ID: 19850944
    [Abstract] [Full Text] [Related]

  • 3. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators.
    N Engl J Med; 2008 Feb 28; 358(9):877-87. PubMed ID: 18305265
    [Abstract] [Full Text] [Related]

  • 4. Sepsis and pharmacogenomics: can the VAS(S)T majority of vasopressor treatment be individualized?*.
    Westphal M, van Haren FM.
    Crit Care Med; 2014 Aug 28; 42(8):1944-5. PubMed ID: 25029134
    [No Abstract] [Full Text] [Related]

  • 5. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST, Shah P, Hollands JM, Shah RA, Shannon WD, Kollef MH.
    Surg Infect (Larchmt); 2007 Apr 28; 8(2):189-200. PubMed ID: 17437364
    [Abstract] [Full Text] [Related]

  • 6. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ, VANISH Investigators.
    JAMA; 2016 Aug 02; 316(5):509-18. PubMed ID: 27483065
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD, Magee C, Moran P, Bastin MLT, Flannery AH.
    J Intensive Care Med; 2019 Sep 02; 34(9):761-765. PubMed ID: 28750598
    [Abstract] [Full Text] [Related]

  • 8. Leucyl/cystinyl aminopeptidase gene variants in septic shock.
    Nakada TA, Russell JA, Wellman H, Boyd JH, Nakada E, Thain KR, Thair SA, Hirasawa H, Oda S, Walley KR.
    Chest; 2011 May 02; 139(5):1042-1049. PubMed ID: 21330387
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ, Cadiz ML, Natavio AM.
    Ann Pharmacother; 2020 Mar 02; 54(3):213-218. PubMed ID: 31625395
    [Abstract] [Full Text] [Related]

  • 10. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
    Russell JA, Lee T, Singer J, Boyd JH, Walley KR, Vasopressin and Septic Shock Trial (VASST) Group.
    Crit Care Med; 2017 Jun 02; 45(6):940-948. PubMed ID: 28333757
    [Abstract] [Full Text] [Related]

  • 11. Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock.
    Nakada TA, Russell JA, Boyd JH, McLaughlin L, Nakada E, Thair SA, Hirasawa H, Oda S, Walley KR.
    Crit Care Med; 2011 Jul 02; 39(7):1641-8. PubMed ID: 21423001
    [Abstract] [Full Text] [Related]

  • 12. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.
    Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, Park CHL, Fukushima JT, Rizk SI, Szeles TF, Dos Santos Neto NC, Filho RK, Galas FRBG, Landoni G.
    Crit Care Med; 2019 Dec 02; 47(12):1743-1750. PubMed ID: 31609774
    [Abstract] [Full Text] [Related]

  • 13. Normal-range blood lactate concentration in septic shock is prognostic and predictive.
    Wacharasint P, Nakada TA, Boyd JH, Russell JA, Walley KR.
    Shock; 2012 Jul 02; 38(1):4-10. PubMed ID: 22552014
    [Abstract] [Full Text] [Related]

  • 14. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.
    Pharmacotherapy; 2004 Aug 02; 24(8):1002-12. PubMed ID: 15338849
    [Abstract] [Full Text] [Related]

  • 15. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.
    Russell JA, Fjell C, Hsu JL, Lee T, Boyd J, Thair S, Singer J, Patterson AJ, Walley KR.
    Am J Respir Crit Care Med; 2013 Aug 01; 188(3):356-64. PubMed ID: 23796235
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
    Menich BE, Miano TA, Patel GP, Hammond DA.
    Ann Pharmacother; 2019 Sep 01; 53(9):877-885. PubMed ID: 30957512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.